Abstract
In the ancient Rome, average life duration was 23 years; in Sweden at the end of the eighteenth century, 36.6 years for women and 33.7 for men; and in many European countries at the beginning of the twenty-first century, life expectancy was 72 and 76 years, respectively. The menopause (period in women’s life 1 year after the last menstruation until the end of life) and involutive hypoandrogenism in males (testosterone below 12 nmol/L and typical symptoms) are characterized by decrease of gonadal steroids and initiating of cardiovascular diseases (CVD). Rahman [1] found that women who entered early menopause (40–45 years) had 40% increase of heart disease. Meta-analysis confirmed these data (Table 16.1).
References
Rahman I (2015) Relationship between age at natural menopause and risk of heart failure. Menopause 1:12–16
Rossouw JE, Prentice RL, Manson JE et al (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465–1477
Genevieve A (2011) Lipids, menopause and early atherosclerosis in SWAN heart women. Menopause 18:376–384
Rossano (2012) Lancet 673:60367–60365
Laughlin GA, Barret-Connor E (2008) Low serum testosterone and mortality in older men. J Clin Endocr Metab 93:68–75
Goldmeyer S (2014) Cardiovascular autonomic dysfunction in primary ovarian insufficiency:clinical and experimental evidence. Am J Trans Res 6:91–101
Mendelsohn ME (2005) Molecular and cellular basis of cardiovascular gender differences. Science 10:1583–1587
Webb CM, Mc Neil JG et al (1999) Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. J Am College Cardiol 83:437–439
Maranon R, Reckelhoff J (2013) Sex and gender differences in control of blood pressure. Clin Sci (Lond) 125:311–318
Vikam T, Schirmer H, Hjolstad I (2009) Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso study. Eur J Endo 161:435–442
Velarde M (2014) Mitochondrial and sex steroid hormone cross talk during aging. Longevity Health Span 3:2–10
Johnson B, Zheng W, Korach K et al (1997) Increased expression of the cardiac L-type Ca channel in ER-deficient mice. J Gen Psychiolo 110:135–140
Yang P, Clausy CE (2011) Gender-based differences in cardiac diseases. J Biomed Res 25:81–83
Dogan M, Akpak Y, Yiginer O (2016) The effects of menstrual cycle on cardiac conduction system. Crescent J Med Biol Sci 3:37–39
Ayaz O, Howlett SE (2015) Testosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanism. Biol Sex Differ 6:9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 International Society of Gynecological Endocrinology
About this chapter
Cite this chapter
Vujovic, S. et al. (2018). How to Prevent Cardiovascular Disorders: Influence of Gonadal Steroids on the Heart. In: Birkhaeuser, M., Genazzani, A. (eds) Pre-Menopause, Menopause and Beyond. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-63540-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-63540-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-63539-2
Online ISBN: 978-3-319-63540-8
eBook Packages: MedicineMedicine (R0)